Zhang, X., Liu, R., Liu, Y., Wei, W., Zhang, Z., Gao, J., Guo, S., Han, H., Zhou, F., Dong, P., He, L. (2025). A phase II clinical study of camrelizumab plus apatinib in combination with stereotactic body radiotherapy (SBRT) for advanced non-clear cell renal cell carcinoma (nccRCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.557